Mike Matson
Stock Analyst at Needham
(2.49)
# 2,220
Out of 4,670 analysts
449
Total ratings
48.7%
Success rate
-1.01%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Downgrades: Hold | $109 | $76.04 | +43.35% | 4 | Nov 22, 2024 | |
| MDT Medtronic | Reiterates: Hold | n/a | $86.21 | - | 15 | Nov 20, 2024 | |
| BSX Boston Scientific | Reiterates: Hold | n/a | $90.00 | - | 24 | Nov 18, 2024 | |
| HAE Haemonetics | Reiterates: Buy | $112 | $85.55 | +30.92% | 9 | Nov 15, 2024 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $1.00 | +150.25% | 16 | Nov 14, 2024 | |
| OCX OncoCyte | Reiterates: Buy | $4.25 | $2.71 | +56.83% | 15 | Nov 13, 2024 | |
| ICUI ICU Medical | Reiterates: Hold | n/a | $168.46 | - | 4 | Nov 13, 2024 | |
| FNA Paragon 28 | Maintains: Buy | $11 → $13 | $10.04 | +29.48% | 14 | Nov 13, 2024 | |
| LIVN LivaNova | Reiterates: Buy | $75 | $51.32 | +46.14% | 21 | Nov 12, 2024 | |
| INGN Inogen | Reiterates: Hold | n/a | $9.38 | - | 13 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $26.34 | +59.45% | 19 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $214.34 | - | 10 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $44 | $39.59 | +11.14% | 14 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7.25 | $3.47 | +108.93% | 16 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $46.67 | +39.28% | 11 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $39.33 | - | 19 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $172.96 | - | 21 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $16.39 | +15.92% | 21 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $191.71 | - | 7 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $109 | $105.33 | +3.48% | 21 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $244.84 | - | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $97 | $74.91 | +29.49% | 22 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $110.22 | - | 24 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $19.02 | - | 15 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $40 | $35.74 | +11.94% | 28 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $49.66 | - | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $393 → $409 | $384.85 | +6.28% | 4 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $243.78 | - | 13 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $78.97 | +13.97% | 15 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $28.27 | +6.12% | 13 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $12.56 | +234.39% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $84.72 | -11.47% | 1 | Feb 18, 2021 |
TransMedics Group
Nov 22, 2024
Downgrades: Hold
Price Target: $109
Current: $76.04
Upside: +43.35%
Medtronic
Nov 20, 2024
Reiterates: Hold
Price Target: n/a
Current: $86.21
Upside: -
Boston Scientific
Nov 18, 2024
Reiterates: Hold
Price Target: n/a
Current: $90.00
Upside: -
Haemonetics
Nov 15, 2024
Reiterates: Buy
Price Target: $112
Current: $85.55
Upside: +30.92%
Lucid Diagnostics
Nov 14, 2024
Reiterates: Buy
Price Target: $2.5
Current: $1.00
Upside: +150.25%
OncoCyte
Nov 13, 2024
Reiterates: Buy
Price Target: $4.25
Current: $2.71
Upside: +56.83%
ICU Medical
Nov 13, 2024
Reiterates: Hold
Price Target: n/a
Current: $168.46
Upside: -
Paragon 28
Nov 13, 2024
Maintains: Buy
Price Target: $11 → $13
Current: $10.04
Upside: +29.48%
LivaNova
Nov 12, 2024
Reiterates: Buy
Price Target: $75
Current: $51.32
Upside: +46.14%
Inogen
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $9.38
Upside: -
Nov 8, 2024
Reiterates: Buy
Price Target: $42
Current: $26.34
Upside: +59.45%
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $214.34
Upside: -
Nov 7, 2024
Maintains: Buy
Price Target: $37 → $44
Current: $39.59
Upside: +11.14%
Nov 7, 2024
Reiterates: Buy
Price Target: $7.25
Current: $3.47
Upside: +108.93%
Nov 7, 2024
Reiterates: Buy
Price Target: $65
Current: $46.67
Upside: +39.28%
Nov 7, 2024
Reiterates: Hold
Price Target: n/a
Current: $39.33
Upside: -
Nov 6, 2024
Reiterates: Hold
Price Target: n/a
Current: $172.96
Upside: -
Nov 6, 2024
Reiterates: Buy
Price Target: $19
Current: $16.39
Upside: +15.92%
Nov 1, 2024
Reiterates: Hold
Price Target: n/a
Current: $191.71
Upside: -
Oct 31, 2024
Reiterates: Buy
Price Target: $109
Current: $105.33
Upside: +3.48%
Oct 31, 2024
Reiterates: Hold
Price Target: n/a
Current: $244.84
Upside: -
Oct 31, 2024
Reiterates: Buy
Price Target: $97
Current: $74.91
Upside: +29.49%
Oct 31, 2024
Reiterates: Hold
Price Target: n/a
Current: $110.22
Upside: -
Oct 31, 2024
Reiterates: Hold
Price Target: n/a
Current: $19.02
Upside: -
Oct 30, 2024
Maintains: Buy
Price Target: $34 → $40
Current: $35.74
Upside: +11.94%
Oct 30, 2024
Reiterates: Hold
Price Target: n/a
Current: $49.66
Upside: -
Oct 30, 2024
Maintains: Buy
Price Target: $393 → $409
Current: $384.85
Upside: +6.28%
Oct 25, 2024
Reiterates: Hold
Price Target: n/a
Current: $243.78
Upside: -
Oct 15, 2024
Reiterates: Buy
Price Target: $90
Current: $78.97
Upside: +13.97%
Sep 27, 2024
Reiterates: Buy
Price Target: $30
Current: $28.27
Upside: +6.12%
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $12.56
Upside: +234.39%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $84.72
Upside: -11.47%